Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2007-12-28
2009-10-20
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C435S320100
Reexamination Certificate
active
07604808
ABSTRACT:
The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccine, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.
REFERENCES:
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5106733 (1992-04-01), Baker et al.
patent: 5382425 (1995-01-01), Cochran et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5498413 (1996-03-01), Casal Alvarez et al.
patent: 5545412 (1996-08-01), Eppstein et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5587164 (1996-12-01), Sanderson et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5719131 (1998-02-01), Harris et al.
patent: 5756103 (1998-05-01), Paoletti et al.
patent: 5770212 (1998-06-01), Falkner et al.
patent: 5795872 (1998-08-01), Ricigliano et al.
patent: 5811103 (1998-09-01), Meyers et al.
patent: 5820869 (1998-10-01), Wasmoen et al.
patent: 5833975 (1998-11-01), Paoletti et al.
patent: 5888513 (1999-03-01), Plana Duran et al.
patent: 5910488 (1999-06-01), Nabel et al.
patent: 5990091 (1999-11-01), Tartaglia et al.
patent: 6004777 (1999-12-01), Tartaglia et al.
patent: 6015694 (2000-01-01), Dubensky, Jr. et al.
patent: 6019980 (2000-02-01), Li et al.
patent: 6033904 (2000-03-01), Cochran et al.
patent: 6143734 (2000-11-01), Garvey et al.
patent: 6165493 (2000-12-01), Neurath et al.
patent: 6207165 (2001-03-01), Audonnet et al.
patent: 6217883 (2001-04-01), Allan et al.
patent: 6287856 (2001-09-01), Poet et al.
patent: 6368601 (2002-04-01), Allan et al.
patent: 6391314 (2002-05-01), Allan et al.
patent: 6475779 (2002-11-01), Mathiowitz et al.
patent: 6497883 (2002-12-01), Bublot et al.
patent: 6517843 (2003-02-01), Ellis et al.
patent: 6573081 (2003-06-01), Bernhardt et al.
patent: 6660272 (2003-12-01), Allan et al.
patent: 6703023 (2004-03-01), Jestin et al.
patent: 6794163 (2004-09-01), Liu et al.
patent: 7148015 (2006-12-01), Jestin et al.
patent: 7179472 (2007-02-01), Jestin et al.
patent: 7223407 (2007-05-01), Jestin et al.
patent: 7223594 (2007-05-01), Jestin et al.
patent: 7244433 (2007-07-01), Jestin et al.
patent: 7258865 (2007-08-01), Jestin et al.
patent: 7261898 (2007-08-01), Jestin et al.
patent: 7297537 (2007-11-01), Jestin et al.
patent: 7314628 (2008-01-01), Jestin et al.
patent: 2002/0055189 (2002-05-01), Bernhardt et al.
patent: 2002/0106639 (2002-08-01), Wang et al.
patent: 2002/0177216 (2002-11-01), Liu et al.
patent: 2003/0170616 (2003-09-01), Wang et al.
patent: 2005/0058653 (2005-03-01), Ellis et al.
patent: 10044648 (2002-03-01), None
patent: 0 737 750 (1996-10-01), None
patent: 1 386 617 (2008-03-01), None
patent: 2 422 956 (1979-11-01), None
patent: 2 518 755 (1983-06-01), None
patent: 2769322 (1999-04-01), None
patent: 2772047 (1999-06-01), None
patent: 1 538 305 (1994-12-01), None
patent: WO 90/11092 (1990-10-01), None
patent: WO 92/05255 (1992-04-01), None
patent: WO 94/01133 (1994-01-01), None
patent: WO 94/21797 (1994-09-01), None
patent: WO 94/27238 (1994-11-01), None
patent: WO 94/27435 (1994-12-01), None
patent: WO 95/11307 (1995-04-01), None
patent: WO 96/34109 (1996-10-01), None
patent: WO 96/40931 (1996-12-01), None
patent: WO 96/40945 (1996-12-01), None
patent: WO 98/40499 (1998-09-01), None
patent: WO 99/18214 (1999-04-01), None
patent: WO 99/29717 (1999-06-01), None
patent: WO 99/29871 (1999-06-01), None
patent: WO 00/01409 (2000-01-01), None
patent: WO 00/24428 (2000-05-01), None
patent: WO 00/77188 (2000-12-01), None
patent: WO 00/77216 (2000-12-01), None
patent: WO 01/96377 (2002-06-01), None
patent: WO 02/10299 (2002-12-01), None
U.S. Appl. No. 60/069,750, filed Dec. 16, 1997, Wang et al.
U.S. Appl. No. 60/069,233, filed Dec. 11, 1997, Wang et al.
Derwent Abstract of French Patent Appl. No. 2 422 956, 1979.
Derwent Abstract of French Patent Appl. No. 2 518 755, 1983.
Derwent Abstract of German Patent Appl. No. 10044648, 2002.
DMRIE structure, Printed from PubChem Compund Summary 2008.
ABI-Prism , “Automated DNA Sequencing, Chemistry Guide”, Applied Biosystems, product manual, applicable to automated sequencers ABI Prism 310, 377 and 373 (2000).
Adams, Mark D. et al. “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project,”Science, 1651-1656. (1991).
Albina et al., “Premiers résultats du CNEVA sur le dépérissement fatal du porcelet en fin de post-sevrage”La Semaine Veterinaire des Filieres, 26:1-2, Nov. 30, 1996.
Allan et al., “Porcine Circoviruses: A Review,”J Vet Diagn Invest. 12: 3-14 (2000).
Allan et al., “Immunostimulation, PCV-2 and PMWS,”Veterinary Record(2000); 147(6):170-171.
Allan, G.M., et al., “Production, preliminary characterisation and applications of monoclonal antibodies to porcine circovirus,”Veterinary Immunology and Immunopathology, 43 (1994) 357-371.
Allan, G.M. et al., “Pathogenesis of porcine circovirus;experimental infections of colostrum deprived piglets and examination of pig fetal material,”Vet. Microbiol., (1995) 44: 49-64.
Allan, G. M. et al., “Isolation of Procine Circovirus-like Viruses from Pigs with a Wasting Disease in the USA and Europe”,Journal of Veterinary Diagnostic Investigation, vol. 10, pp. 3-10, Jan. 1998, XP 002068503.
Altmann, Curtis R. et al. “Microarray-Based Analysis of Early Development inXenopus laevis,”Developmental Biology, 236:64-75 (2001).
Author Unknown, GenBank info on AF027217 (Revised Jul. 5, 2002).
Author Unknown, NCBI Sequence Revision History of AF027217 (Revised Jul. 5, 2002).
Bantle, John A. et al. “Phase III Interlaboratory Study of FETAX Part 3. FETAX Validation using 12 Compounds with and without an Exogenous Metabolic Activation System,”Journal of Applied Toxicology, 19:447-472 (1999).
Barany, F.,PNAS. USA, (1991) 88: 189-193.
Behr, J.P., “Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy”Bioconjugate Chem. 5(5):382-389 (1994).
Bei, R. et al., “The Use of a Cationic Liposome Formulation (DOTAP) Mixed with a Recombinant Tumor-Associated Antigen to Induce Immune Responses and Protective Immunity in Mice,”Journal of Immunotherapy, 21(3):159-169 (1998).
Blanchard et al., “An ORF2 Protein-Based Elisa for Procine Circovirus Type 2 Antibodies in Post-Weaning Multisystemic Wasting Syndrome”,Veterinary Microbiology,(2003) 94:183-184.
Blanchard et al., “Protection of Swine Against Post-Weaning Multisystemic Wasting Syndrome (PMWS) by Porcine Circovirus Type 2 (PCV2) Proteins”,Vaccine(2003) 21:4565-4575.
Buckholz, R.G., “Yeast systems for the expression of heterologous gene products.”Curr. Op. Biotechnology(1993) 4:538-542.
Burg, J.L. et al., “Single-molecule detection of RNA reporter probes by amplification with QB replicase,”Mol. and Cell. Probes, (1996) 10: 257-271.
Cho et al., “Enhanced cellular immunity of hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization,”Vaccine17:1136-1144 (1999).
Chu, B.C.F. et al., “Synthesis of an amplifiable reporter RNA for bioassays,”NAR, (1986) 14: 5591-5603.
Chu, P.W.G. et al., “Putative full length clones of the genomic DNA segments of subterranean cover stunt virus and identification of the segment coding for the viral coat protein,”Virus Research, (1993) 27: 161-171.
Chu, Te-hua Terina et al., “Toward Highly Efficient Cell-Type-Specific Gene Transf
Albina Emmanuel
Arnauld Claire
Blanchard Philippe
Cann Pierre Le
Cariolet Roland
Bingham & McCutchen LLP
Salimi Ali R.
Wyeth
LandOfFree
Circovirus sequences associated with piglet weight loss... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Circovirus sequences associated with piglet weight loss..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Circovirus sequences associated with piglet weight loss... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108740